Co-expression network of IS and OSA. حسب Zhe Wu (582498)

الموضوعات:

App user retention trends. حسب Henri Claude Moungui (22227043)

الموضوعات:

Data derived from Google Play Console for the WHO SkinNTDs. app. حسب Henri Claude Moungui (22227043)

الموضوعات:

All data points from Fig 3. حسب Sara Hijazi (21656615)

الموضوعات:

Data Extraction Sheet: A sheet that contains the data that we extracted from the included studies. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Analysis of differences in baseline data among pre- and postmenopausal women with different levels of physical activity. حسب Song Chen (69646)

الموضوعات:

Install base trends in Cameroon vs Ethiopia, Ghana and Kenya. حسب Henri Claude Moungui (22227043)

الموضوعات:

Premenopausal depression symptom estimation network model for different physical activities. حسب Song Chen (69646)

الموضوعات:

The UL4 mutation alleviated inflammation in PRV-infected mice. حسب Xiaohua Zhang (350570)

الموضوعات:

Data for Fig 5D. حسب Xiaohua Zhang (350570)

الموضوعات:

Demographic characteristics of the participants. حسب MD. Nahid Hassan Nishan (22264861)

الموضوعات:

Subgroup analysis of Lactate level based on surgery type. حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

Forest plot of other outcomes (Lactate, Mortality, and Inotropic use). حسب Mohamed R. Abdelraouf (21501468)

الموضوعات:

The UL4 mutation alleviated inflammasome activation and pyroptosis in PRV-infected cells. حسب Xiaohua Zhang (350570)

الموضوعات:

Comparison between juvenile and adult demyelination. حسب Sara Hijazi (21656615)

الموضوعات:

PRV UL4 is a promotor of NLRP3 inflammasome activation. حسب Xiaohua Zhang (350570)

الموضوعات:

Effect of AUT00201 (1 µM) on PV properties after juvenile demyelination. حسب Sara Hijazi (21656615)

الموضوعات:

Participant Flowchart. حسب Jiuming Li (11711375)

الموضوعات:

Histopathological appearance of the liver. حسب Ayça Toprak-Semiz (22582110)

الموضوعات:

The UL4 null mutation alleviated inflammasome activation in PRV-infected cells. حسب Xiaohua Zhang (350570)

الموضوعات: